This meant GLP-1 would need to be given in high doses if it was to have any therapeutic potential
These products are not FDA-approved, have not been reviewed by FDA for safety and effectiveness, and FDA cautions they can lead to serious and potentially life-threatening adverse health consequences including infections and sepsis. Knock-off versions of semaglutide pose significant threats to peoples health and safety, a Novo Nordisk spokesperson said in an email to Healio | Endocrine Today
Corrigendum: Decreased risk of anxiety in Diabetic patients receiving Glucagon-Like Peptide-1 receptor agonist: a Nationwide, Population-based Cohort Study
This widespread use of these popular weight loss drugs, both for approved diabetes treatment and off-label weight loss, has now resulted in thousands of patients reporting severe gastrointestinal injuries and vision loss, conditions that many allege were not adequately disclosed on warning labels when they began treatment
For instance, whey protein has a particularly high impact, significantly enhancing satiety and lowering post-meal blood glucose levels
Christensen, R., Kristensen, P
